Cohance Life

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE03QK01018
  • NSEID: COHANCE
  • BSEID: 543064
INR
438.05
-2.3 (-0.52%)
BSENSE

Sep 18, 03:30 PM

BSE+NSE Vol: 7.63 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 1003386,
    "name": "Cohance Life",
    "stock_name": "Cohance Life",
    "full_name": "Cohance Lifesciences Ltd",
    "name_url": "stocks-analysis/cohance-life",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "438.05",
    "chg": -2.3,
    "chgp": "-0.52%",
    "dir": -1,
    "prev_price": "440.35",
    "mcapval": "16,869.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 543064,
    "symbol": "COHANCE",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "sector_id": 65,
    "indexname": "India SENSEX",
    "isin": "INE03QK01018",
    "curr_date": "Sep 18, 03:30 PM",
    "curr_time": "02:39 AM",
    "last_traded_at": "Sep 18, 03:30 PM IST",
    "bse_nse_vol": "7.63 lacs",
    "exc_status": "Active",
    "traded_date": "Sep 18, 2026",
    "traded_date_str": "2026 09 18",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/cohance-life-1003386-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Cohance Lifesciences Ltd Technical Momentum Shifts Amid Bearish Outlook",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/cohance-lifesciences-ltd-technical-momentum-shifts-amid-bearish-outlook-4196794",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/CohanceLifescie_technicaldot_4196794.png",
        "date": "2026-09-18 08:04:30",
        "description": "Cohance Lifesciences Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, moving from a mildly bearish stance to a sideways trend. Despite a modest daily gain of 1.64%, the company’s overall technical indicators and fundamental scores suggest a challenging outlook, with the MarketsMOJO Mojo Grade recently downgraded from Sell to Strong Sell."
      },
      {
        "title": "Cohance Lifesciences Ltd Faces Technical Momentum Shift Amid Bearish Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/cohance-lifesciences-ltd-faces-technical-momentum-shift-amid-bearish-signals-4194287",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/CohanceLifescie_technicaldot_4194287.png",
        "date": "2026-09-16 08:09:18",
        "description": "Cohance Lifesciences Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, signalling a transition from a sideways trend to a mildly bearish stance. Despite some mildly bullish daily moving averages, the broader technical indicators suggest caution for investors as the stock continues to underperform the benchmark Sensex and faces deteriorating momentum across weekly and monthly charts."
      },
      {
        "title": "Cohance Lifesciences Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/cohance-lifesciences-ltd-is-rated-sell-4193161",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/CohanceLifescie_mojoScore_4193161.png",
        "date": "2026-09-15 10:11:10",
        "description": "Cohance Lifesciences Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 21 August 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 15 September 2026, providing investors with an up-to-date view of the company’s performance and outlook."
      },
      {
        "title": "Cohance Lifesciences Ltd Technical Momentum Shifts Amid Prolonged Downtrend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/cohance-lifesciences-ltd-technical-momentum-shifts-amid-prolonged-downtrend-4188622",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/CohanceLifescie_technicaldot_4188622.png",
        "date": "2026-09-10 08:04:40",
        "description": "Cohance Lifesciences Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, moving from a mildly bullish stance to a sideways trend. Despite some positive signals on shorter timeframes, the broader monthly indicators remain bearish, reflecting ongoing challenges for the stock amid a difficult market environment."
      },
      {
        "title": "Cohance Lifesciences Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/cohance-lifesciences-ltd-is-rated-sell-4182525",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/CohanceLifescie_mojoScore_4182525.png",
        "date": "2026-09-04 10:10:05",
        "description": "Cohance Lifesciences Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 21 August 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 04 September 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance."
      },
      {
        "title": "Cohance Lifesciences Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/cohance-lifesciences-ltd-is-rated-sell-4166895",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/CohanceLifescie_mojoScore_4166895.png",
        "date": "2026-08-24 10:10:04",
        "description": "Cohance Lifesciences Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 21 August 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 24 August 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance."
      },
      {
        "title": "Cohance Lifesciences Gains 4.90%: 2 Key Technical Signals Drive Weekly Momentum",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/cohance-lifesciences-gains-490-2-key-technical-signals-drive-weekly-momentum-4165075",
        "imagepath": "",
        "date": "2026-08-22 12:00:55",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>17 Aug:</strong> Stock opens at Rs.444.70, up 0.84% despite Sensex decline</p>\n                    <p><strong>18 Aug:</strong> Strong 2.32% gain to Rs.455.00 on increased volume</p>\n                    <p><strong>20 Aug:</strong> Intraday high surge of 7.45%, reaching Rs.480</p>\n                    <p><strong>21 Aug:</strong> Formation of Golden Cross signals potential bullish breakout</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.441.00</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-valu..."
      },
      {
        "title": "Cohance Lifesciences Ltd Forms Golden Cross Amid Mixed Technical Signals and Weak Fundamentals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/cohance-lifesciences-ltd-forms-golden-cross-indicating-potential-bullish-breakout-4164533",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/CohanceLifescie_goldencross_4164533.png",
        "date": "2026-08-21 18:00:31",
        "description": "The 50-day moving average for Cohance Lifesciences Ltd has crossed above the 200-day moving average, creating a golden cross on 21 Aug 2026. However, this technical event arrives amid a complex backdrop of contradictory indicators and a fundamental profile that tempers enthusiasm."
      },
      {
        "title": "Cohance Lifesciences Ltd Surges 7.24% to Day's High of Rs 480 — Outperforms Sector by 6.61 Percentage Points",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/cohance-lifesciences-ltd-hits-intraday-high-with-745-surge-on-20-aug-2026-4162772",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/CohanceLifescie_priceRelatedfactors_4162772.png",
        "date": "2026-08-20 11:47:03",
        "description": "The Sensex advanced 0.68% on 20 Aug 2026, yet Cohance Lifesciences Ltd outpaced the broader market with a robust 7.24% gain, reaching an intraday high of Rs 480. This 6.61 percentage-point outperformance over its Pharmaceuticals & Biotechnology sector peers signals a distinctly stock-specific momentum shift rather than a mere market tailwind."
      }
    ],
    "total": 593,
    "sid": "1003386",
    "stock_news_url": "https://www.marketsmojo.com/news/cohance-lifesciences-1003386"
  },
  "announcements": [
    {
      "caption": "Completion Of USFDA Inspection",
      "datetime": "05-Sep-2026",
      "details": "Completion of USFDA Inspection",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
      "datetime": "03-Sep-2026",
      "details": "Press Release",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Outcome for Outcome Of The Committee Meeting",
      "datetime": "03-Sep-2026",
      "details": "Outcome of Committee Meeting",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Cohance Lifesciences Ltd has declared <strong>100%</strong> dividend, ex-date: 09 Sep 22",
          "dt": "2022-09-09",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Cohance Lifesciences Ltd has announced <strong>1:1</strong> bonus issue, ex-date: 25 Sep 20",
          "dt": "2020-09-25",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock newsNews and Views
stock-recommendationAnnouncement

Completion Of USFDA Inspection

05-Sep-2026 | Source : BSE

Completion of USFDA Inspection

Announcement under Regulation 30 (LODR)-Press Release / Media Release

03-Sep-2026 | Source : BSE

Press Release

Board Meeting Outcome for Outcome Of The Committee Meeting

03-Sep-2026 | Source : BSE

Outcome of Committee Meeting

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

Cohance Lifesciences Ltd has declared 100% dividend, ex-date: 09 Sep 22

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

Cohance Lifesciences Ltd has announced 1:1 bonus issue, ex-date: 25 Sep 20

stock-summary
RIGHTS

No Rights history available